Opening book details…
Can I read Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM‐P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non‐Hodgkin's lymphoma on EtoBox?
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM‐P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non‐Hodgkin's lymphoma by Ian Chau; Mark Harries; David Cunningham; Mark Hill; Paul J. Ross; Caroline D. Archer; Andrew R. Norman; Andrew Wotherspoon; Dow Mu Koh; Kairen Gill; Maggie Uzzell; Yvonne Prior; Daniel Catovsky is a Medicine article available to read on EtoBox.
What is Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM‐P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non‐Hodgkin's lymphoma about?
**Summary.** This study was designed to assess the efficacy and safety of gemcitabine, cisplatin and methylprednisolone (GEM‐P) for patients with relapsed or refractory Hodgkin's disease (HD) and non‐Hodgkin's lymphoma. Twenty‐one patients were treated with gemcitabine (1000 mg/m^2^ d 1, 8 and 15), cisplatin (100 mg/m^2^ d 15) and methylprednisolone (1000 mg d 1–5) given every 28 d. Of these, 20 patients were evaluable for response. The median age was 38 years (range 17–64 years). Histological subtypes were: nodular sclerosing HD (__n__ = 10), diffuse large B cell (__n__ = 5), T cell‐rich B cell (__n__ = 2), follicular (__n__ = 2), mantle cell (__n__ = 1) and enteropathy‐associated T‐cell lymphoma (__n__ = 1). The median remission duration prior to receiving GEM‐P was only 42 d. The overall objective response rate was 80%[95% confidence interval (CI): 56–94%], including five complete and 11 partial responses. GEM‐P induced responses in all histological subtypes, primary progressive disease and patients who had received a previous autograft. The only grade 3–4 toxicity was myelosuppression. However, no cases of febrile neutropenia or haemorrhage with thrombocytopenia were encountere
Who reads Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM‐P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non‐Hodgkin's lymphoma?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Ian Chau; Mark Harries; David Cunningham; Mark Hill; Paul J. Ross; Caroline D. Archer; Andrew R. Norman; Andrew Wotherspoon; Dow Mu Koh; Kairen Gill; Maggie Uzzell; Yvonne Prior; Daniel Catovsky
- Publisher
- John Wiley and Sons; Wiley (Blackwell Publishing); Blackwell Publishing Inc.; Wiley (ISSN 0007-1048)
- Published
- 2003
- Language
- EN
- Field
- Medicine (Health Sciences)